Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening
- PMID: 24495335
- PMCID: PMC4234000
- DOI: 10.1111/1471-0528.12574
Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening
Abstract
Objective: To determine risk of Down syndrome (DS) in multiple relative to singleton pregnancies, and compare prenatal diagnosis rates and pregnancy outcome.
Design: Population-based prevalence study based on EUROCAT congenital anomaly registries.
Setting: Eight European countries.
Population: 14.8 million births 1990-2009; 2.89% multiple births.
Methods: DS cases included livebirths, fetal deaths from 20 weeks, and terminations of pregnancy for fetal anomaly (TOPFA). Zygosity is inferred from like/unlike sex for birth denominators, and from concordance for DS cases.
Main outcome measures: Relative risk (RR) of DS per fetus/baby from multiple versus singleton pregnancies and per pregnancy in monozygotic/dizygotic versus singleton pregnancies. Proportion of prenatally diagnosed and pregnancy outcome.
Statistical analysis: Poisson and logistic regression stratified for maternal age, country and time.
Results: Overall, the adjusted (adj) RR of DS for fetus/babies from multiple versus singleton pregnancies was 0.58 (95% CI 0.53-0.62), similar for all maternal ages except for mothers over 44, for whom it was considerably lower. In 8.7% of twin pairs affected by DS, both co-twins were diagnosed with the condition. The adjRR of DS for monozygotic versus singleton pregnancies was 0.34 (95% CI 0.25-0.44) and for dizygotic versus singleton pregnancies 1.34 (95% CI 1.23-1.46). DS fetuses from multiple births were less likely to be prenatally diagnosed than singletons (adjOR 0.62 [95% CI 0.50-0.78]) and following diagnosis less likely to be TOPFA (adjOR 0.40 [95% CI 0.27-0.59]).
Conclusions: The risk of DS per fetus/baby is lower in multiple than singleton pregnancies. These estimates can be used for genetic counselling and prenatal screening.
Keywords: Concordance; Down syndrome; monozygotic and dizygotic pregnancies; multiple births; pregnancy outcomes; twins.
© 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.
Figures



References
-
- Cuckle H. Down’s syndrome screening in twins. J Med Screen. 1998;5:3–4. - PubMed
-
- Sebire NJ. Anomalous development in twins (including monozygotic duplication) In: Kilby MD, Baker P, Critchley H, Field D, editors. Multiple Pregnancy. 1st edn. London: RCOG; 2006. pp. 55–83.
-
- Madsen HN, Ball S, Wright D, Torring N, Petersen OB, Nicolaides KH, et al. A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol. 2011;37:38–47. - PubMed
-
- Cahill AG, Macones GA, Stamilio DM, Dicke JM, Crane JP, Odibo AO. Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol. 2009;200:257.e1–e6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical